Skip to main content

General Catalyst Group Management, LLC

Position in AVBP — ArriVent BioPharma, Inc.

CIK 1637946 Cambridge, MA

Position in AVBP

as of Jun 30, 2026 · filed Aug 17, 2026
Position Value
$51,928,865
+$17,444,152 QoQ
Shares Held
1,494,786
0.0% QoQ
Ownership
3.03%
of shares outstanding
% of Portfolio
27.55%
of 13F equity value
Holder Rank
#13
of 158 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in AVBP Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

General Catalyst Group Management, LLC holds $149,679,586 across 6 Biotechnology names. AVBP ranks #1 (34.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 AVBP
ArriVent BioPharma, Inc.
This page
1,494,786 $51,928,865

All Filings in AVBP

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $51,928,865 1,494,786
2026-03-31 $34,484,713 1,494,786
2025-12-31 $30,075,094 1,494,786
2025-09-30 $27,578,801 1,494,786
2025-06-30 $32,541,491 1,494,786
2025-03-31 $27,638,593 1,494,786
2024-12-31 $39,821,099 1,494,786
2024-09-30 $35,127,471 1,494,786
2024-06-30 $27,728,280 1,494,786
2024-03-31 $26,696,877 1,494,786